Silver Book Fact

Mortality rates in the first 3 months after a heart attack have fallen by about 75%.

Cutler, David M. Are the Benefits of Medicine Worth What We Pay for It? 15th Annual Herbert Lourie Memorial Lecture on Health Policy. Center for Policy Research Briefs. 2004; 27. http://ideas.repec.org/p/max/cprpbr/27.html

Reference

Title
Are the Benefits of Medicine Worth What We Pay for It? 15th Annual Herbert Lourie Memorial Lecture on Health Policy
Publication
Center for Policy Research Briefs
Publication Date
2004
Authors
Cutler, David M
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.  
  • Hospitalization from incorrect diagnosis of heart attacks costs $12 billion per year. If creatine kinase, myoglobin and troponin are used for detecting heart attack in ER patients with chest pain,…  
  • Stroke rates among Afib patients
    In one year, 58,283 of the 1.265 million Medicare beneficiaries with atrial fibrillation that did not receive prophylaxis suffered a stroke. For those who did receive anti-coagulants, 38,468 suffered strokes.  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Primary angioplasty reduces 30-day mortality risk by 34% to 50%.